Lv56
980 积分 2023-12-13 加入
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer
1小时前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
1小时前
已完结
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
1天前
待确认
Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy
1天前
求助中
Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy
1天前
已完结
A decade of progress in small-cell lung cancer (2015–2025): a narrative review
3天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
7天前
已完结
Exploring the immunological effects of antibody–drug conjugates
7天前
已完结
The Five-Decade Journey of Small Cell Lung Cancer
9天前
已完结
Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies
9天前
已完结
皖公网安备34019202002308
